Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Bay

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireA Le Bourgeois, M Labopin, D Blaise, et al.
Bone Marrow Transplantation|June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and EurocordS Nguyen, A Achour, L Souchet, et al.
Journal De Mycologie Medicale|November 15, 2017
[French recommendations on control measures to reduce the infectious risk in immunocompromised patients]J-R Zahar, S Jolivet, H Adam, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Bone Marrow Transplantation|June 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMTA Kanellopoulos, M Labopin, A Spyridonidis, et al.
Bone Marrow Transplantation|November 24, 2015
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)A C Mamez, V Lévy, P Chevallier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireA Le Bourgeois, M Labopin, D Blaise, et al.
Bone Marrow Transplantation|June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and EurocordS Nguyen, A Achour, L Souchet, et al.
Journal De Mycologie Medicale|November 15, 2017
[French recommendations on control measures to reduce the infectious risk in immunocompromised patients]J-R Zahar, S Jolivet, H Adam, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Bone Marrow Transplantation|June 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMTA Kanellopoulos, M Labopin, A Spyridonidis, et al.
Bone Marrow Transplantation|November 24, 2015
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)A C Mamez, V Lévy, P Chevallier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
Pageof 8